Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Beijing Municipal Science & Technology Commission | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine the better preoperative anti-tuberculosis treatment period of patients with spinal tuberculosis.
Quality assurance plan:All the investigators will receive uniform training. Standard cases follow-up,collection,management systems will be established.The process of cases follow-up,collection,management will be supervised by the third party.Data entry will be in the manner of independent parallel entry.The endpoints events are judged by third party.Statistical analysis are implemented by the statistics institutions of the third party.In order to control the bias,this study takes multicenter,random,control study design.
Sample size assessment:Under the condition of multicenter,random,control design, computational formula takes the rate comparisons of two groups.The key endpoints event is soft tissue width of vertebral side measured by computed tomography. The incidence of the key endpoints event in two weeks group is 30%.The incidence of the key endpoints event in four weeks group is 15%.When alpha value is 0.5 and power value is 0.9,the sample size is 161 patients.If loses visit rate is 20%,the sample size is 194 patients.
Statistical analysis plan:The key events are analyzed by chi-squared test.The statistical significance factors among them are calculated by relative risk.
Data checks and source data verification are supervised by a third-party organization (contract research organization,CRO).
Standard Operating Procedures:Investigator's brochure has explained in detail about the standard operating procedures of everything.Data dictionary can be found in standard operating procedures.
Plan for missing data: The investigators Set a 20% rate of lost to follow-up.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| anti-tuberculosis treatment two weeks | Experimental | anti-tuberculosis drugs All the patients in the groups receive anti-tuberculosis treatment with Isoniazid 0.3g po qd, Rifampicin 0.45g po qd, Ethambutol 0.75 g po qd,Pyrazinamide 0.5g po tid. for two weeks. |
|
| anti-tuberculosis treatment four weeks | Experimental | anti-tuberculosis drugs All the patients in the groups receive anti-tuberculosis treatment with Isoniazid 0.3g po qd, Rifampicin 0.45g po qd, Ethambutol 0.75 g po qd,Pyrazinamide 0.5g po tid. for four weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Isoniazid | Drug | preoperative treatment of spinal tuberculosis with Isoniazid |
|
| Measure | Description | Time Frame |
|---|---|---|
| Vertebral side width of soft tissue is measured by CT after operation. | up to 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Amount of bone trabecula between bone graft surfaces is measured by X-ray after operation. | up to 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| shibing qin, doctor | Contact | 86+10+13581557856 | ly13785361227@163.com | |
| shi bi qin, doctor | Contact |
| Name | Affiliation | Role |
|---|---|---|
| shao fa xu, doctor | Beijing Chest Hospital | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing chest hospital | Recruiting | Beijing | Beijing Municipality | 101149 | China |
Not provided
| ID | Term |
|---|---|
| D014399 | Tuberculosis, Spinal |
| D014376 | Tuberculosis |
| ID | Term |
|---|---|
| D014394 | Tuberculosis, Osteoarticular |
| D000092225 | Tuberculosis, Extrapulmonary |
| D009164 | Mycobacterium Infections |
| D000193 | Actinomycetales Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D007538 | Isoniazid |
| D012293 | Rifampin |
| D004977 | Ethambutol |
| D011718 | Pyrazinamide |
| ID | Term |
|---|---|
| D006834 | Hydrazines |
| D009930 | Organic Chemicals |
| D007539 | Isonicotinic Acids |
| D000147 | Acids, Heterocyclic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Rifampicin | Drug | preoperative treatment of spinal tuberculosis with Rifampicin |
|
| Ethambutol | Drug | preoperative treatment of spinal tuberculosis with Ethambutol |
|
| Pyrazinamide | Drug | preoperative treatment of spinal tuberculosis with Pyrazinamide |
|
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D001850 | Bone Diseases, Infectious |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D013166 | Spondylitis |
| D013122 | Spinal Diseases |
| D006571 |
| Heterocyclic Compounds |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D012294 | Rifamycins |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D047029 | Lactams, Macrocyclic |
| D047028 | Macrocyclic Compounds |
| D011083 | Polycyclic Compounds |
| D005029 | Ethylenediamines |
| D003959 | Diamines |
| D011073 | Polyamines |
| D000588 | Amines |
| D011719 | Pyrazines |